P3-14-08: A Phase II Study of Gemcitabine and Carboplatin (GC) Plus Iniparib (BSI-201) as Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer
Telli, ML, Kurian, AW, Jensen, KC, Vinayak, S, Flaherty, P, Lipson, JA, Wapnir, I, Daniel, B, Carlson, RW, Mills, MA, Chang, P-J, Schackmann, E, Rocha, C, Sherman, B, Blackwood-Chirchir, A, Bradley, C, Ford, JM
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Get full text
Journal Article
P4-10-10: Breast Cancer Risk Factors among Asian Versus Caucasian Women with BRCA1/2 Mutations
de, Bruin MA, Kwong, A, Goldstein, BA, Lipson, JA, Ikeda, DM, McPherson, LA, Sharma, B, Kardashian, A, Schackmann, EA, Kingham, KE, Mills, MA, West, DW, Ford, JM, Kurian, AW
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Get full text
Journal Article